NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1942311832 M.D.
Verify on CMS → Chris Tsimerekis, M.D.
Endocrinology, Diabetes & Metabolism Physician in Fountain Valley, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,078 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 168 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
36%
generic claims · 53% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
CMS neutral threshold · no category scores published
Industry payments
$885.91
26 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Chris Tsimerekis, M.D. carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 1,897 Medicare Part D claims in 2024.
- 75/100
- CMS neutral score · not measured
- 2K
- Part D claims, 2024
- 36%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Chris Tsimerekis, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1942311832), first enumerated 08/31/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,897 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
CMS assigned a neutral MIPS final score of 75/100 where no performance category was scored — not a measured quality rank.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$885.91 in reported industry payments (26 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
California statewide board action statistics are published annually — these figures describe aggregate state activity, not Chris Tsimerekis, M.D.'s individual license status. Verify directly with the state medical board.
Source: MBC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1942311832 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-NEUTRAL · RX-MID · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1942311832
- ENUM-LEGACY 2006
- TAX-MID 8K Endocrinology, Diabetes
- MIPS-NEUTRAL 75/100
- RX-MID 1,897
- BOOK-LIGHT 890 in California
- PHOTO-ENUM Stephen Quevedo · 2006
Chris Tsimerekis, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
1,897 ≥ 83rd percentile 83% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Chris Tsimerekis, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Chris Tsimerekis, M.D.?
CMS neutral score, not measuredPrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
1,897 31% vs specialty avg
MIPS final score
75/100
Specialty distribution in California
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among California providers
MIPS score not measured
CMS assigned a neutral 75/100 threshold
CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1942311832 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 08/31/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
CMS neutral threshold · not measured
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Chris Tsimerekis, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$886
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Chris Tsimerekis, M.D.. To verify Chris Tsimerekis, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Chris Tsimerekis, M.D. - brand share 53.0%
Endocrinology, Diabetes & Metabolism Physician average
53% brand-name claims vs 36% generic, on 1,897 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,897
Total Claims
$610K
Total Drug Cost
168
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 3,452.133
- Total Day Supply
- 102,618
- Brand vs Generic
- 53% brand / 36% generic
- Brand Drug Cost
- $581K
- Generic Drug Cost
- $9K
Patient Demographics
- Average Patient Age
- 75.3 years
- Avg HCC Risk Score
- 1.70
- Gender Split
- 63% female / 38% male
- Age Distribution
- <65: 11, 65-74: 63, 75-84: 74, 85+: 20
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Chris Tsimerekis, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Synthroid
Synthroid
215 claims
- Metformin Hcl
Metformin Hcl
150 claims
- Levothyroxine Sodium
Levothyroxine Sodium
141 claims
- Ozempic
Ozempic
119 claims
- Nano 2nd Gen Pen N… 81
Nano 2nd Gen Pen Needle
81 claims
- Trulicity 81
Trulicity
81 claims
- Glipizide 78
Glipizide
78 claims
- Jardiance 75
Jardiance
75 claims
| Drug | Claims |
|---|---|
| Synthroid Levothyroxine Sodium | 215 |
| Metformin Hcl | 150 |
| Levothyroxine Sodium | 141 |
| Ozempic Semaglutide | 119 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 81 |
| Trulicity Dulaglutide | 81 |
| Glipizide | 78 |
| Jardiance Empagliflozin | 75 |
| Januvia Sitagliptin Phosphate | 51 |
| Farxiga Dapagliflozin Propanediol | 50 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in CA →
All providers in California →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Chris Tsimerekis, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
8,078
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,739
Avg Claims per Provider
Chris Tsimerekis, M.D.'s 1,897 claims are below the specialty average of 2,739.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Tsimerekis, both outside California so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (75 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Tsimerekis.
One of 890 Endocrinology, Diabetes & Metabolism Physician providers enrolled in California, 5 are shown here.
Dr. Anita Abraham
M.D.
Stockton, CA
Dr. Sallie Adams
M.D.
Roseville, CA
Ananta Addala
Palo Alto, CA
Dr. Helen Adelberg
M.D.
Encino, CA
Dr. David Aftergood
MD
Beverly Hills, CA
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Chris Tsimerekis, M.D.'s specialty? ▼
Chris Tsimerekis, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Fountain Valley, California. Credentials: M.D..
How much does Chris Tsimerekis, M.D. prescribe under Medicare Part D? ▼
In 2024, Chris Tsimerekis, M.D. wrote 1,897 Medicare Part D claims totaling $610K in drug costs for 168 beneficiaries.
What is Chris Tsimerekis, M.D.'s Medicare quality score? ▼
Chris Tsimerekis, M.D. has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Chris Tsimerekis, M.D. located? ▼
Chris Tsimerekis, M.D. is located at 11100 WARNER AVE, Fountain Valley, CA, 92708. Phone: (714) 549-9927.
What is Chris Tsimerekis, M.D.'s NPI number? ▼
Chris Tsimerekis, M.D.'s National Provider Identifier (NPI) is 1942311832, issued on 08/31/2006.
Does Chris Tsimerekis, M.D. prescribe more brand-name or generic drugs? ▼
Chris Tsimerekis, M.D.'s prescribing is 53% brand-name and 36% generic drugs by claim count, with $581K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 8,078 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,739 Medicare Part D claims per year.
What drugs does Chris Tsimerekis, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Chris Tsimerekis, M.D.'s most frequently prescribed drugs include Synthroid, Metformin Hcl, Levothyroxine Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Chris Tsimerekis, M.D. accept Medicare? ▼
Chris Tsimerekis, M.D. appears in CMS Medicare data with 1,897 Part D claims and 168 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Chris Tsimerekis, M.D.'s credentials? ▼
Chris Tsimerekis, M.D.'s NPI is 1942311832 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.